NONINVASIVE ASSESSMENT OF ULCERATIVE COLITIS ACTIVITY IN CHILDREN

Timely diagnosis and monitoring of ulcerative colitis (UC) in children is extremely relevant. In recent years, much attention has been paid to improving noninvasive UC diagnosis methods, which are available and convenient in the practice of a doctor. In this regard, we analyzed the significance of changes in noninvasive laboratory parameters of sick children with different clinical and endoscopic UC activity. Materials and methods. A prospective analysis of data of 80 patients diagnosed with UC at the age of 1 to 18 years with varying degrees of clinical and endoscopic activity of the disease was performed. Results. Significant changes in the studied laboratory parameters’ levels were revealed depending on the degree of clinical and endoscopic UC activity in children. The changes in fecal calprotectin content, levels of albumin, hemoglobin, and platelets were particularly substantial and informative in the blood of sick children when comparing remission with moderate and high clinical and endoscopic UC activity. A decrease in platelet counts was also found when UC activity increased. Conclusion. The studied laboratory parameters are informative noninvasive markers of UC activity in children. These indices can be used in the diagnosis of UC activity and monitoring of the course of the disease.

Князев О.В., Шкурко Т.В., Каграманова А.В., Веселов А.В., Никонов Е.Л. Эпидемиология воспалительных заболеваний кишечника. Современное состояние проблемы (обзор литературы). Доказательная гастроэнтерология. 2020; 9(2): 66-73. https://doi. org/10.17116/dokgastro2020902166

Conrad M.A., Rosh J.R. Pediatric inflammatory bowel disease. Pediatr. Clin. North. Am. 2017; 64(3): 577-91. https://doi.org/10.1016/j.pcl.2017.01.005

Oliveira S.B., Monteiro I.M. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017; 357: j2083. https://doi.org/10.1136/bmj.j2083

Wilson D.C., Russell R.K. Overview of paediatric IBD. Semin. Pediatr. Surg. 2017; 26(6): 344-8. https://doi.org/10.1053/j.sempedsurg.2017.10.002

Dilillo D., Zuccotti G.V., Galli E., Meneghin F., Dell’Era A., Penagini F., et al. Noninvasive testing in the management of children with suspected inflammatory bowel disease. Scand. J. Gastroenterol. 2019; 54(5): 586-91. https://doi.org/10.1080/00365521.2019.1604799

Siow V.S., Bhatt R., Mollen K.P. Management of acute severe ulcerative colitis in children. Semin. Pediatr. Surg. 2017; 26(6): 367-72. https://doi.org/10.1053/j.sempedsurg.2017.10.006

Turner D., Otley A.R., Mack D., Hyams J., Bruijne J., Uusoue K., et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133(2): 423-32. https://orcid.org/10.1053/j.gastro.2007.05.029

Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 2012; 61(4): 535-42. https://doi.org/10.1136/gutjnl-2011-300486

Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013; 145(5): 987-95. https://doi.org/10.1053/j.gastro.2013.07.024

Daperno M., Comberlato M., Bossa F., Biancone L., Bonanomi A., Cassinotti A., et al. Interobserver agreement in IBD scores requires expertise and education: Preliminary results from an ongoing IG-IBD study. Dig. Liver. Dis. 2011; 46(11): 969-73. https://doi.org/10.1016/j.dld.2014.07.010

Fuller M.K. Pediatric inflammatory bowel disease: special considerations. Surg. Clin. North. Am. 2019; 99(6): 1177-83. https://doi.org/10.1016/j.suc.2019.08.008

Maaser C., Sturm A., Vavricka S.R., Kucharzik T., Fiorino G., Annese V., et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohns Colitis. 2019; 13(2): 144-64. https://doi.org/10.1093/ecco-jcc/jjy113.

Öztürk Z.A., Dag M.S., Kuyumcu M.E., Cam H., Yesil Y., Yilmaz N., et al. Could platelet indices be new biomarkers for inflammatory bowel diseases? Eur. Rev. Med. Pharmacol. Sci. 2013; 17(3): 334-41.

Voudoukis E., Karmiris K., Koutroubakis I.E. Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. World J. Gastroenterol. 2014; 20(12): 3180-90. https://doi.org/10.3748/wjg.v20.i12.3180

Aljomah G., Baker S.S., Schmidt K., Alkhouri R., Kozielski R., Zhu L., et al. Anemia in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2018; 67(3): 351-5. https://doi.org/10.1097/MPG.0000000000002002

Miller S.D., Cuffari C., Akhuemonkhan E., Guerrerio A.L., Lehmann H., Hutfless S. Anemia screening, prevalence, and treatment in pediatric inflammatory bowel disease in the United States, 2010-2014. Pediatr. Gastroenterol. Hepatol. Nutr. 2019; 22(2): 152-61. https://doi.org/10.5223/pghn.2019.22.2.152

Cioffi M., De Rosa A., Serao R., Picone I., Vietri M.T. Laboratory markers in ulcerative colitis: Current insights and future advances. World J. Gastrointest. Pathophysiol. 2015; 6(1): 13-22. https://doi.org/10.4291/wjgp.v6.i1.13

Matowicka-Karna J. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases. Postepy. Hig. Med. Dosw. (Online). 2016; 70: 305-12. https://doi.org/10.5604/17322693.1199305